3Krolewski A S. Genetits of diabetic nephropathy: evidence for major and minor gene effectscts[J]. Kidney Int, 1999,55: 1582- 1596.
4Rogus J J, Krolewski A S. Using discordant sibpairs to map loci for qualitative traits with high sibling recurrence risk [J]. Am J Hum Genet, 1996,59 : 1376-1381.
5Faronato P P, Maioli M, Tonolo G, et al. Clustering of albumin excretion rate abnormalities in caucasian patients with NIDDM: the Italy NIDDM nephropathy study group [J]. Diabetologia, 1997,40:816-823.
6Krolewski M, Eggers P, Warram J H, et al. Magmitude of end- stage renal disease in IDDM: a 35 year followup study[J]. Kidney Int, 1993,50 : 2041-2046.
8Maoczulski D K, Rogus J J, Antonellis A, et al. Major susceptibility locus for nephropathy in typel diabetes mellitus on chromosome 3q: results of novel discordant sibpair analy sis[J]. Diabetes, 1998,47:1164-1169.
9Rogus J J, Moczulski D K, Freire M B, et al. Diabetic nephropathy is associated with AGT polyrnorphism T235 : results of a family-based study[J].Hypertension, 1998,31 : 627-631.
10Imperatore G, Hanson R L, Pettitt D J, et al. Sibpair linkage analysis for susceptibility genes for microvascular complications arnaong pima indians with type2 diabetes millitus[J]. Diabetes, 1998,47:821-830.
5Matloubian M, David A, Engel S, et al. A transmem- brane CXC chemokine is a ligand for HIV-coreceptor Bonzo[ J]. Nat Immunol, 2000, 1 (4):298-304.
6Lin Z, Gong Q, Zhou Z, et al. Increased plasma CXCL16 levels in patients with chronic kidney diseases [ J ]. Eur J Clin Invest, 2011, 41 ( 8 ) :836-845.
7Zhu SS, Ren Y, Zhang M, et al. Wlds protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice [ J]. Diabetologia, 2011, 54 (9) : 2440-2450.
8Ludwig A, Weber C. Transmembrane chemokines: versa- tile 'special agents' in vascular inflammation[ J]. Thromb Haemost, 2007, 97 (5) :694-703.
9Yi GW, Zeng QT, Mao XB, et al. Overexpression of CX- CL16 promotes a vulnerable plaque phenotype in apoh- poprotein E-knockout mice[ J ]. Cytokine, 2011, 53 (3) : 320-326.
